Gene · 10562
Papers1,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of monochromatic light on self-renewal and differentiation of intestinal stem cells in broilers. | Poult Sci | 2025 | 40701004 | PubTator, text mining | PubMed |
| Effect of thermomechanical aging on fracture strength of anterior crowns fabricated with different CAD-CAM materials. | J Adv Prosthodont | 2025 | 40687195 | PubTator, text mining | PubMed |
| Exosomes derived from colostrum and mature human breast milk protect against experimental necrotizing enterocolitis. | Pediatr Surg Int | 2025 | 40676257 | PubTator, text mining | PubMed |
| Mesenchymal WNT2B is required for the development and function of the human intestine. | bioRxiv | 2025 | 40654667 | PubTator, text mining | PubMed |
| Proteomic Landscape of Colorectal Cancer Derived Liver Metastasis Reveals Three Distinct Phenotypes With Specific Signaling and Enhanced Survival. | Mol Cell Proteomics | 2025 | 40617497 | PubTator, text mining | PubMed |
| AntagomiR-192-5p-engineered exosomes encapsulated in MXene-modified GelMA hydrogel facilitated epithelization of burn wounds by targeting OLFM4. | Bioact Mater | 2025 | 40575328 | PubTator, text mining | PubMed |
| Exploring the Clinical Implication of S100A9 in Ulcerative Colitis and Its Progression to Cancer: A Journey from Inflammation to Cancer. | Int J Mol Sci | 2025 | 40565156 | PubTator, text mining | PubMed |
| Robust Serum Proteomic Signatures of APOE2. | bioRxiv | 2025 | 40501769 | PubTator, text mining | PubMed |
| Olfactomedin-4 elevation in pediatric acute respiratory distress syndrome. | Am J Physiol Lung Cell Mol Physiol | 2025 | 40499529 | PubTator, text mining | PubMed |
| Spatial transcriptomics from pancreas and local draining lymph node tissue reveals a lymphotoxin-β signature in human type 1 diabetes. | bioRxiv | 2025 | 40475580 | PubTator, text mining | PubMed |
| Brown adipose tissue secretes OLFM4 to coordinate sensory and sympathetic innervation via Schwann cells. | Nat Commun | 2025 | 40467585 | PubTator, text mining | PubMed |
| miR-181a-5p mediates the effects of BMP4 on intestinal cell proliferation and differentiation. | Cell Death Dis | 2025 | 40436833 | PubTator, text mining | PubMed |
| The Association of OLFM4 with the Progression and Cisplatin Resistance of Head and Neck Squamous Carcinoma. | Curr Oncol | 2025 | 40422535 | PubTator, text mining | PubMed |
| Robust hierarchical co-clustering for exploring toxicogenomic biomarkers and their chemical regulators. | Sci Rep | 2025 | 40369321 | PubTator, text mining | PubMed |
| Deciphering the Metabolic Impact and Clinical Relevance of N-Glycosylation in Colorectal Cancer through Comprehensive Glycoproteomic Profiling. | Adv Sci (Weinh) | 2025 | 40285620 | PubTator, text mining | PubMed |
| Discovery of the first isoform-specific sGC activator: Selective activation of GC-1 by runcaciguat. | Eur J Pharmacol | 2025 | 40147578 | PubTator, text mining | PubMed |
| Clinical efficacy and chemoresistance analysis of precision neoadjuvant chemotherapy for borderline resectable pancreatic cancer: a prospective, single-arm pilot study. | Int J Surg | 2025 | 40146255 | PubTator, text mining | PubMed |
| Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics. | Cells | 2025 | 40136707 | PubTator, text mining | PubMed |
| Olfactomedin 4 promotes gastric cancer cell G2/M progression and serves as a therapeutic target in gastric adenocarcinoma. | Carcinogenesis | 2025 | 40056162 | PubTator, text mining | PubMed |
| Apolipoprotein E ε4-Specific Relationship Between Serum Olfactomedin 4 and Alzheimer's Disease. | Mol Neurobiol | 2025 | 40055292 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10562/papers?page=5